Sæmundur Rögnvaldsson
Sæmundur Rögnvaldsson publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Chronic Lymphocytic Leukemia Research.
- World rank
- #2,416,733 of 7,710,434 ranked researchers
- Rank in Iceland
- #919 of 2,050
- Works
- 87
- Citations
- 749
- Citations per work
- 8.6
What does Sæmundur Rögnvaldsson research?
Sæmundur Rögnvaldsson's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5765.1%
- Medicine5765.1%
- Life Sciences1618.3%
- Everything else1416.6%
- 1Hematology35% of their works
- 2Molecular Biology15% of their works
- 3Genetics13% of their works
- 4Oncology13% of their works
- 5Epidemiology4% of their works
- 6Immunology3% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Chronic Lymphocytic Leukemia Research
- Cancer Treatment and Pharmacology
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Glycosylation and Glycoproteins Research
- Platelet Disorders and Treatments
Which keywords describe Sæmundur Rögnvaldsson's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, Cardiac Amyloidosis, Transthyretin, Chronic Lymphocytic Leukemia, Genomic Aberrations and Chemotherapy-Induced Peripheral Neuropathy.
- Platelets
- Glycans
- AML
- JAK2 Mutation
- Chemotherapy-Induced Peripheral Neuropathy
- Chronic Lymphocytic Leukemia
- Cardiac Amyloidosis
- International Myeloma Working Group
- Diagnosis Criteria
- Prognostic Factors
- Transthyretin
- Genomic Aberrations
- Taxanes
- Myelofibrosis
- Acute Myeloid Leukemia
- Glycosylation
- Thrombosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Diagnosis Criteria681 topic
- International Myeloma Working Group681 topic
- Prognostic Factors262 topics
- Cardiac Amyloidosis231 topic
- Transthyretin231 topic
- Chronic Lymphocytic Leukemia201 topic
- Genomic Aberrations201 topic
- Chemotherapy-Induced Peripheral Neuropathy141 topic
- Taxanes141 topic
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- Glycans41 topic
- Glycosylation41 topic
- Platelets41 topic
- Thrombosis41 topic
Where does Sæmundur Rögnvaldsson work?
Sæmundur Rögnvaldsson's main affiliation in the publication record is University of Iceland, Iceland.
How many publications and citations does Sæmundur Rögnvaldsson have?
OpenAlex counts 87 works and 749 citations for Sæmundur Rögnvaldsson, an h-index of 13, ranking #2,416,733 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sæmundur Rögnvaldsson. Posts are plain text and can be reported.